Skip to main content
Tulane Home Tulane Home

Genitourinary Clinical Trials

EA8143
A Phase III Randomized Study Comparing PERioperative Nivolumab vs. Observation in Patients with Renal Cell Carcinoma Undergoing Nephrectomy (PROSPER RCC)
More Information

 

NEKTAR
A Phase 3 Randomized Open Label Study to Compare NKTR-214 Combined with Nivolumab to the TUHC Investigator's Choice of Sunitinib or Cabozantinib in Patients with Previously Untreated Advanced Renal Cell Carcinoma
More Information